标题
Molecular and genomic characterisation of a panel of human anal cancer cell lines
作者
关键词
-
出版物
Cell Death & Disease
Volume 12, Issue 11, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-10-19
DOI
10.1038/s41419-021-04141-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The repertoire of mutational signatures in human cancer
- (2020) Ludmil B. Alexandrov et al. NATURE
- Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer
- (2020) Marsha-Kay N. D. Hutchinson et al. ONCOGENE
- Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
- (2019) Shin Hye Yoo et al. Scientific Reports
- Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
- (2018) Rangaswamy Govindarajan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Salvage Surgery for Locoregional Failure in Anal Squamous Cell Carcinoma
- (2018) Glen R. Guerra et al. DISEASES OF THE COLON & RECTUM
- E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line
- (2018) Erin Isaacson Wechsler et al. JOURNAL OF GENERAL VIROLOGY
- The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies
- (2018) C. M. van Leeuwen et al. Radiation Oncology
- Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences
- (2018) Wulfran Cacheux et al. Cancer Medicine
- Ki67 is a Graded Rather than a Binary Marker of Proliferation versus Quiescence
- (2018) Iain Miller et al. Cell Reports
- LBA21InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial
- (2018) S Rao et al. ANNALS OF ONCOLOGY
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- RE: Anal cancer: different epidemiological and clinical definitions
- (2017) Farhad Islami et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
- (2017) Van K Morris et al. LANCET ONCOLOGY
- Epidemiology of Anal Canal Cancer
- (2017) Valerie M. Nelson et al. Surgical Oncology Clinics of North America
- Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
- (2017) Cody Warren et al. Viruses-Basel
- JAK Mutations as Escape Mechanisms to Anti–PD-1 Therapy
- (2017) Aurelien Marabelle et al. Cancer Discovery
- Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma
- (2017) Wulfran Cacheux et al. Oncotarget
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes
- (2016) J. H. Chung et al. ANNALS OF ONCOLOGY
- Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
- (2016) Wulfran Cacheux et al. BRITISH JOURNAL OF CANCER
- Biomarkers in anal cancer: from biological understanding to stratified treatment
- (2016) Christopher M Jones et al. BRITISH JOURNAL OF CANCER
- Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
- (2016) Kent W. Mouw et al. CLINICAL CANCER RESEARCH
- FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
- (2016) Ronglai Shen et al. NUCLEIC ACIDS RESEARCH
- VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
- (2016) Zhongwu Lai et al. NUCLEIC ACIDS RESEARCH
- Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer
- (2016) X. Le et al. Cancer Discovery
- Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing
- (2015) C. H. Chung et al. ANNALS OF ONCOLOGY
- Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor Xenografts
- (2015) Matthew Read et al. ANNALS OF SURGICAL ONCOLOGY
- HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
- (2015) D Meulendijks et al. BRITISH JOURNAL OF CANCER
- 500 Pembrolizumab (MK-3475) for PD-L1-positive squamous cell carcinoma (SCC) of the anal canal: Preliminary safety and efficacy results from KEYNOTE-028
- (2015) P.A. Ott et al. EUROPEAN JOURNAL OF CANCER
- High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis
- (2015) Ivona Baricevic et al. EUROPEAN JOURNAL OF CANCER
- APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma
- (2015) David S H Liu et al. GUT
- Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention
- (2015) Maria-Pia Bernardi et al. LANCET ONCOLOGY
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human papillomavirus DNA load and p16INK4aexpression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy
- (2014) Franz Rödel et al. INTERNATIONAL JOURNAL OF CANCER
- APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development
- (2014) Stephen Henderson et al. Cell Reports
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- mTORC1 Inhibition Is Required for Sensitivity to PI3K p110 Inhibitors in PIK3CA-Mutant Breast Cancer
- (2013) M. Elkabets et al. Science Translational Medicine
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- A framework for variation discovery and genotyping using next-generation DNA sequencing data
- (2011) Mark A DePristo et al. NATURE GENETICS
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Establishment and characterization of the human SaTM-1 anal canal squamous cell carcinoma cell line derived from lymph node metastasis
- (2009) Takeda INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started